“…Finally, the number of nonculprit, asymptomatic, potentially type-switching plaques may be such, especially in cases of high atherosclerotic burden 5 that renders, in combination with the above, all efforts at localized "vulnerability-guided" treatment, without the ability to accurately assess implications futile, if not dangerous. 126 Despite the above, the apparent shortcomings of the vulnerable plaque hypothesis are not attributed to it having been superseded by our ability to prevent, diagnose, and treat coronary atherosclerosis. Rather, current widespread interpretation and focus on imaging and still-frame structural features have significantly diverged from the original concept, with regard to which we have only covered half the necessary path.…”